55 related articles for article (PubMed ID: 20940535)
1. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.
Garg G; Shah JP; Liu JR; Bryant CS; Kumar S; Munkarah A; Morris RT
Int J Gynecol Cancer; 2010 Oct; 20(7):1201-6. PubMed ID: 20940535
[TBL] [Abstract][Full Text] [Related]
2. Uterine leiomyosarcoma in asian patients: validation of the revised Federation of gynecology and obstetrics staging system and identification of prognostic classifiers.
Tan PS; Koh E; Pang C; Ong WS; Ngo L; Soh LT; Quek R; Chay WY; Ho TH; Tay SK; Chew SH; Lim-Tan SK; Khoo-Tan H; Lim SL; Busmanis I; Goh LK; Chia YN; Chia WK; Lim T
Oncologist; 2012; 17(10):1286-93. PubMed ID: 22829569
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.
Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
Eur J Cancer; 2024 Apr; 201():113913. PubMed ID: 38377777
[TBL] [Abstract][Full Text] [Related]
4. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single-Institution Patient Cohort.
Vengaloor Thomas T; Reddy KK; Gandhi S; Nittala MR; Abraham A; Robinson W; Ridgway M; Packianathan S; Vijayakumar S
Cureus; 2021 Nov; 13(11):e19289. PubMed ID: 34877225
[TBL] [Abstract][Full Text] [Related]
5. FIGO 2023 endometrial staging: a leap of faith into the new "prognostic based' rather than "anatomical based" staging-too fast too furious??
Bassetty KC; Begum D; Barmon D; Baruah U; Gupta S; Kumar M; Nath J; Khanikar D; Bhattacharyya M; Roy PS
J Cancer Res Clin Oncol; 2024 May; 150(5):251. PubMed ID: 38733417
[TBL] [Abstract][Full Text] [Related]
6. Improved clinical trial enrollments for uterine leiomyosarcoma patients after gynecologic oncology partnership with a sarcoma center.
Lange SE; Liu J; Adkins DR; Powell MA; Van Tine BA; Mutch DG
Gynecol Oncol; 2016 Feb; 140(2):307-12. PubMed ID: 26718726
[TBL] [Abstract][Full Text] [Related]
7. Prognostic performance of the 2023 FIGO staging schema for endometrial cancer.
Matsuo K; Chen L; Klar M; Lee MW; Machida H; Mikami M; Muderspach LI; Carlson JW; Roman LD; Wright JD
Gynecol Oncol; 2024 May; 187():37-45. PubMed ID: 38713997
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of Controversies and Unresolved Issues in the 2014 FIGO Staging System for Endometrial Cancer: Survey Results From Members of the International Society of Gynecological Pathologists and International Gynecologic Cancer Society.
Kayraklioglu N; Katsakhyan L; Cohen PA; Singh N; Rabban JT; Matias-Guiu X
Int J Gynecol Pathol; 2024 May; 43(3):242-252. PubMed ID: 37668357
[TBL] [Abstract][Full Text] [Related]
9. Surgically treated pelvic liposarcoma and leiomyosarcoma: The effect of tumor size on cancer-specific survival.
Baudo A; Piccinelli ML; Incesu RB; Morra S; Scheipner L; Barletta F; Tappero S; Garcia CC; Assad A; Tian Z; Acquati P; de Cobelli O; Longo N; Briganti A; Terrone C; Chun FKH; Tilki D; Ahyai S; Saad F; Shariat SF; Carmignani L; Karakiewicz PI
Surg Oncol; 2024 Jun; 54():102074. PubMed ID: 38615387
[TBL] [Abstract][Full Text] [Related]
10. The Malignant Potential of Ovarian Steroid Cell Tumors Revisited: A Multi-institutional Clinicopathologic Analysis of 115 Cases.
Fadare O; Fard EV; Bhargava R; Desouki MM; Hanley KZ; Ip PPC; Li JJX; Lu B; Medeiros F; Ng JHY; Parkash V; Pinto A; Quick CM; Skala SL; Tokuyama M; Turashvili G; Wei CH; Xing D; Zheng W; Soong TR; Howitt BE
Am J Surg Pathol; 2024 May; 48(5):570-580. PubMed ID: 38512100
[TBL] [Abstract][Full Text] [Related]
11. Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience.
Wang Z; Shi N; Naing A; Janku F; Subbiah V; Araujo DM; Patel SR; Ludwig JA; Ramondetta LM; Levenback CF; Ramirez PT; Piha-Paul SA; Hong D; Karp DD; Tsimberidou AM; Meric-Bernstam F; Fu S
Cancer Med; 2016 Dec; 5(12):3437-3444. PubMed ID: 27882721
[TBL] [Abstract][Full Text] [Related]
12. Impact of the 2023 FIGO Staging System for Endometrial Cancer on the Use of Imaging Services: An Indian Perspective.
Chandramohan A; Manchanda S; Renganathan R; Popat PB; Shah D; Dhamija E; Sen A
Indian J Radiol Imaging; 2024 Apr; 34(2):309-323. PubMed ID: 38549900
[TBL] [Abstract][Full Text] [Related]
13. Does "One Size Fits All"? Rethinking FIGO Depth of Invasion Measurements in Vulvar Cancer.
Bleeker MCG; Bosse T; van de Vijver KK; Bart J; Horlings H; Jonges TGN; Visser NCM; Kooreman LFS; Bulten J; Ewing-Graham PC
Int J Gynecol Pathol; 2024 Feb; ():. PubMed ID: 38303108
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum to "Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer" Eur. J. Cancer (201) (April) 2024, 113913.
Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
Eur J Cancer; 2024 May; 202():114017. PubMed ID: 38570289
[No Abstract] [Full Text] [Related]
15. The 2023 FIGO Staging System for Endometrial Carcinoma: Predicted Impact on Stage Distribution Based on a Retrospective Analysis of 1169 Cases.
Schilling JM; Shaker N; Shaker N; Fadare O
Am J Surg Pathol; 2024 Jan; 48(1):123-126. PubMed ID: 38117288
[No Abstract] [Full Text] [Related]
16. Leiomyosarcoma of the uterine cervix associated with pregnancy: A case report and review of literature.
Whitcombe DD; Valente PT; Acosta OM; Kost ER
Gynecol Oncol Rep; 2016 Aug; 17():45-8. PubMed ID: 27355001
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of tumor-size-stratified prognostic nomograms for patients with uterine sarcoma: A SEER database analysis.
Cao S; Liao X; Xu K; Xiao H; Shi Z; Zou Y; Li C; Hu Y; Yan S
Cancer Med; 2023 Jan; 12(2):1339-1349. PubMed ID: 35841316
[TBL] [Abstract][Full Text] [Related]
18. Development of a Multi-Institutional Prediction Model for Three-Year Survival Status in Patients with Uterine Leiomyosarcoma (AGOG11-022/QCGC1302 Study).
Tse KY; Wong RW; Chao A; Ueng SH; Yang LY; Cummings M; Smith D; Lai CR; Lau HY; Yen MS; Cheung AN; Leung CK; Chan KS; Chan AN; Li WH; Choi CK; Pong WM; Hui HF; Yuk JY; Yao H; Yuen NW; Obermair A; Lai CH; Ip PP; Ngan HY
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069227
[TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of Nomograms for Predicting the Prognosis of Uterine Leiomyosarcoma: A Population-Based Study.
Meng Y; Yang Y; Zhang Y; Li X
Med Sci Monit; 2020 Apr; 26():e922739. PubMed ID: 32270788
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiotherapy improves local control and survival in patients with uterine leiomyosarcoma.
Wong P; Han K; Sykes J; Catton C; Laframboise S; Fyles A; Manchul L; Levin W; Milosevic M
Radiat Oncol; 2013 May; 8():128. PubMed ID: 23705661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
